...
首页> 外文期刊>Archives of Biological Sciences >Phenotypic expression and founder effect of PANK2 c.1583C>T (p.T528M) mutation in Serbian Pantothenate kinase-associated neurodegeneration patients
【24h】

Phenotypic expression and founder effect of PANK2 c.1583C>T (p.T528M) mutation in Serbian Pantothenate kinase-associated neurodegeneration patients

机译:PANK2 c.1583C> T(p.T528M)突变在塞尔维亚泛酸激酶相关的神经变性患者中的表型表达和创始效应

获取原文
           

摘要

Paper description:Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive disorder caused by mutations in the PANK2 gene which encodes for pantothenate kinase 2. Different PANK2 mutations are detected worldwide, but all 6 Serbian patients showed substitution PANK2 c.1583C>T (p.T528M) in the homozygous or heterozygous state.The phenotypic expression and a possible founder effect of PANK2 c.1583C>T (p.T528M) substitution was examined. The PANK2 c.1583T allele is significantly associated with a particular haplotype. The age of this mutation is estimated at 15 generations ago. PANK2 c.1583C>T in Serbian patients represents a founder mutation with a similar phenotypic expression.: Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by dystonia, parkinsonism, cognitive and visual impairment, and iron accumulation in the brain. Many cases of PKAN result from mutations in the PANK2 gene that encodes pantothenate kinase 2, a key regulatory enzyme in the biosynthesis of coenzyme A. We previously detected six Serbian patients with clinically suggestive PKAN, all of whom had PANK2 c.1583C>T (p.T528M) mutation either in the homozygous or in the heterozygous state. In this study we explored the phenotypic expression and a possible founder effect of this substitution. We performed the analysis of linkage disequilibrium (LD) and organization in haplotypes of 23 single nucleotide polymorphisms (SNPs) adjacent to the PANK2 gene in all of the six patients and their parents, as well as in control healthy child-parents trios. The age of PANK2 c.1583C>T mutation was determined using the r ~(2) degeneration method. Clinical findings in our patients were markedly similar. Different LD structures between patients and controls is revealed, and PANK2 c.1583T allele was significantly associated with a particular haplotype. The age of PANK2 c.1583C>T mutation was estimated to be about 15 generations. Our results suggest that PANK2 c.1583C>T in Serbian PKAN patients represents a founder mutation descended from one common ancestor.
机译:论文描述:泛酸激酶相关的神经变性(PKAN)是一种罕见的常染色体隐性遗传疾病,由编码泛酸激酶2的PANK2基因突变引起。全球检测到不同的PANK2突变,但所有6名塞尔维亚患者均显示出替代PANK2 c.1583C>纯合或杂合状态的T(p.T528M)。检查了PANK2 c.1583C> T(p.T528M)的表型表达和可能的创始效应。 PANK2 c.1583T等位基因与特定单倍型显着相关。此突变的年龄估计在15代前。塞尔维亚人患者中的PANK2 c.1583C> T代表具有相似表型表达的创始人突变。:泛酸激酶相关的神经变性(PKAN)是一种常染色体隐性遗传疾病,其特征为肌张力障碍,帕金森症,认知和视觉障碍以及脑中铁蓄积。许多PKAN病例是由编码泛酸激酶2的PANK2基因突变引起的,泛酸激酶2是辅酶A生物合成中的关键调节酶。我们先前发现了6名具有临床提示性PKAN的塞尔维亚患者,他们均患有PANK2 c.1583C> T( p.T528M)突变处于纯合或杂合状态。在这项研究中,我们探索了表型表达和这种替代的可能的创始人效应。我们进行了连锁不平衡(LD)和组织的分析,在所有6例患者及其父母中,以及在健康的儿童父母三人组中,与PANK2基因相邻的23个单核苷酸多态性(SNP)的单倍型。使用r〜(2)变性方法确定PANK2 c.1583C> T突变的年龄。我们患者的临床发现明显相似。揭示了患者和对照之间的不同LD结构,并且PANK2 c.1583T等位基因与特定单倍型显着相关。 PANK2 c.1583C> T突变的年龄估计约为15代。我们的结果表明,塞尔维亚PKAN患者的PANK2 c.1583C> T代表了一个共同祖先产生的创始人突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号